BIIB vs TRDA · P/E 21, rev $9.89B vs P/E 12, rev $1.8M
Biogen Inc (BIIB) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported TRDA revenue for 2026-06-30 was $1.8M. Net income was -$82.5M. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the BIIB and TRDA stock pages for the full models.
Not investment advice.